EUVIMEDEUVIMED entdecken
Crossref

ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis

Yueqin Zhu, Chun Cao, Zihao Li, Zhou Xu, Shishun Qian, Jingrong Zhang, Mengxue Li, Xiaojie Hu, Anqi Zhang, Na Du, Xuesheng Pan, Xinchen Wang und 3 weitere

International Immunopharmacology · 2024-12 · 143 · 113226

DOI: 10.1016/j.intimp.2024.113226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Yueqin Zhu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Acid Sensing Ion Channels, Liver Cirrhosis, Ferroptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: University Natural Science Research Project of Anhui Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver fibrosis is a sustained process of liver tissue damage and repair caused by various physiological and pathological factors, with the activation and proliferation of hepatic stellate cells being central. Therefore, understanding and clarifying the relevant mechanisms of hepatic stellate cell activation and death is of great clinical significance for the treatment of liver fibrosis diseases. METHODS: In vivo, recombinant adeno-associated virus was used to infect the liver of experimental mice, overexpressing ASIC1a, and based on this, a liver fibrosis model treated with sorafenib was constructed. In vitro, using RNA plasmid technology to transfect HSC-T6 cells, ASIC1a was overexpressed or silenced in the cells, and on this basis, PDGF-BB and Sorafenib were used to stimulate HSC-T6 cells, causing activated HSC-T6 to undergo ferroptosis. RESULTS: The ferroptosis inducers Sorafenib and erastin can induce ferroptosis in HSCs, effectively inhibiting or reversing the progression of liver fibrosis. We found that the expression level of ASIC1a was significantly reduced in the livers of mice with liver fibrosis treated with Sorafenib. After treatment with an adeno-associated virus overexpressing ASIC1a, the therapeutic effect of Sorafenib was inhibited, and the level of ferroptosis induced by Sorafenib was also inhibited. The induction of ferroptosis in hepatic stellate cells in vitro depends on the presence of ASIC1a. By further exploring the potential mechanism, we observed that the overexpression of ASIC1a can promote an increase in YAP nuclear translocation, thereby regulating the activity of Hippo/YAP pathway signaling. After treatment with Sorafenib, the influx of Ca2+ significantly increased when ASIC1a was overexpressed, and BAPTA-AM intervention eliminated the intracellular Ca2+ accumulation induced by ASIC1a overexpression. CONCLUSIONS: This indicated that the activation of YAP depends on the calcium ion influx induced by ASIC1a, which regulates ferroptosis in hepatic stellate cells by regulating the calcium ion-dependent Hippo/YAP pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsAcid Sensing Ion ChannelsLiver CirrhosisFerroptosisYAP-Signaling ProteinsSorafenibHippo Signaling PathwaySignal TransductionAnimalsMiceMice, Inbred C57BLMaleCell LineProtein Serine-Threonine KinasesHumansLiver

Stichwörter der Autor:innen

ASIC1aFerroptosisHSCsHippo/YAP pathwayLiver fibrosis

Substanzen

Acid Sensing Ion ChannelsYAP-Signaling ProteinsSorafenibYap1 protein, mouseProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China; Office of Drug Clinical Trial Institutions, Anhu…
  • Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Shanghai Songjiang District Central Hospital, Shanghai 201600, China.
  • Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
  • Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. Electronic address: wjj@ahmu.edu.cn.
  • Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China. Electronic address: aydhy@126.com.

Förderung

  • University Natural Science Research Project of Anhui Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Anhui Medical University

Zitieren

APA

Zhu, Y., Cao, C., Li, Z., Xu, Z., Qian, S., Zhang, J., Li, M., Hu, X., Zhang, A., Du, N., Pan, X., Wang, X., Sun, Y., Wang, J., & Huang, Y. (2024). ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis. International Immunopharmacology, 143, 113226. https://doi.org/10.1016/j.intimp.2024.113226

Vancouver

Zhu Y, Cao C, Li Z, Xu Z, Qian S, Zhang J, et al. ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis. International Immunopharmacology. 2024;143:113226. doi:10.1016/j.intimp.2024.113226

BibTeX
@article{Zhu2024,
  author = {Zhu, Yueqin and Cao, Chun and Li, Zihao and Xu, Zhou and Qian, Shishun and Zhang, Jingrong and Li, Mengxue and Hu, Xiaojie and Zhang, Anqi and Du, Na and Pan, Xuesheng and Wang, Xinchen and Sun, Yancai and Wang, Jiajia and Huang, Yan},
  title = {ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {143},
  pages = {113226},
  doi = {10.1016/j.intimp.2024.113226}
}
Kostenlos starten →